Deutschland und das Vereinigte Königreich sind attraktive Märkte für Medizintechnik-Unternehmen. Die Gesundheitssysteme und damit auch der Marktzugang und die Erstattung unterscheiden sich stark. In unserer Online-Informationsveranstaltung im Rahmen der Partnerschaftsinitiative BW-UK des Ministeriums für Wirtschaft, Arbeit und Tourismus erhalten Sie eine Übersicht über das National Health System im Vereinigten Königreich sowie über das deutsche Gesundheitssystem. Sie erhalten Einblicke in Struktur, Trends sowie Möglichkeiten und wie Sie Ihre Medizinprodukte erfolgreich integrieren können. Weitere Vorträge stellen unter anderem derzeitige Prioritäten und Innovationsgesuche von NHS Schottland und Wales sowie Möglichkeiten der Zusammenarbeit vor.
Folgende Informationen sind nur auf Englisch verfügbar:
Medical Devices are a strong driver of healthcare innovation. Both Germany and the United Kingdom (UK) are attractive markets for medical technology companies: with Germany being the biggest and the UK the third biggest market in Europe with market shares of 25.6% and 12.1% (2020)1.
However, health systems, market access and reimbursement differ.
The Lunch & Learn gives an overview of both healthcare systems and how medical devices may be introduced and reimbursed in these markets as well as highlighting innovation adoption, opportunities and trends.
Dr. Linda Magee, Health Innovation and NHS Specialist at the Department of International trade, will give an overview on the National Health System (NHS) in the United Kingdom and how medical devices may be introduced and sold to the NHS in her talk "UK Healthcare innovation and how to access the NHS: partnership and process". Michael Weißer, CEO of AiM GmbH - Assessment in Medicine, Research and Consulting, will introduce the german health system in his talk “Health Care and Reimbursement System in Germany: Opportunities for Medical Devices”.
Additionally a talk by Prof. David Lowe (SHIP, Clinical Lead for Innovation West Scotland NHS GGC) and James Blackwood (iCAIRD CTO & NHS Programme Manager, AI Lead at Scottish Health and Industry Partnership), will present the Scottish Health & Industry Partnership which is aimed towards strengthening Scotland’s innovation activities in health and social care in order to solve real problems and improve quality, efficiency and sustainability of healthcare. The talk will give insight into priorities and opportunities to work with NHS Scotland including the test beds for innovation initiative.
An additional talk by Siôn Charles, Head of Strategy and Service Planning at ARCH will highlight opportunities for medtech companies in Wales.
The participation is free of charge and addresses medical technology companies from Baden-Württemberg and the United Kingdom. Registration prior to the event is mandatory.
The event is part of the activities of the Partnership Initiative Baden-Württemberg – United Kingdom of the Ministry of Economic Affairs, Labour and Tourism Baden-Württemberg and is jointly organised by BIOPRO Baden-Württemberg with support of the Department for International Trade, Scottish Development International, Welsh Government and London & Partners.
Moderation: BIOPRO Baden-Württemberg GmbH
11.00 | Words of welcome
11.15 | Short overview
11:25 | UK healthcare innovation and how to access the NHS: Partnership and process
12.00 | Healthcare and reimbursement system in Germany: Opportunities for medical devices
12.40 - 01.00 Coffee break
01.00 | NHS Scotland / Scottish Health and Industry Partnership: Priorities and opportunities for medtech
PROF. DAVID LOWE | Scottish Health and Industry Partnership, Clinical Lead for Innovation West Scotland NHS GGC &
JAMES BLACKWOOD | iCAIRD CTO & NHS Programme Manager, AI Lead at Scottish Health and Industry Partnership
01.30 | ARCH: Opportunities in Wales
01.50 | Close up